ScholarIQanswers from OpenAlex & ORCID
Howard M. Sandler
ResearcherPublications, citations & collaboration network
Howard M. Sandler is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Howard M. Sandler have?
ScholarIQindexed works
Howard M. Sandler has 940 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Howard M. Sandler have?
ScholarIQcitation count
Howard M. Sandler has 48,840 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Howard M. Sandler?
ScholarIQh-index
Howard M. Sandler has an h-index of 104 in OpenAlex.
What is the i10-index of Howard M. Sandler?
ScholarIQi10-index
Howard M. Sandler has an i10-index of 412 in OpenAlex.
What is the ORCID of Howard M. Sandler?
ScholarIQorcid
The ORCID for Howard M. Sandler is on the source record.
What is the OpenAlex record for Howard M. Sandler?
ScholarIQopenalex
The OpenAlex for Howard M. Sandler is on the source record.
What are the most-cited papers on Howard M. Sandler?
ScholarIQmost cited works
Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference
Mack Roach, Gerald E. Hanks, Howard D. Thames, Paul F. Schellhammer, William U. Shipley, Gerald H. Sokol, Howard M. Sandler
Association of Black Race With Prostate Cancer–Specific and Other-Cause Mortality
Robert T. Dess, Holly Hartman, Brandon A. Mahal, Payal Soni, Will Jackson, Matthew R. Cooperberg, Christopher L. Amling, William J. Aronson, Christopher J. Kane, Martha K. Terris, Zachary S. Zumsteg, Santino Butler, Joseph R. Osborne, Todd M. Morgan, Rohit Mehra, Simpa S. Salami, Amar U. Kishan, Chenyang Wang, Edward M. Schaeffer, Mack Roach, Thomas M. Pisansky, William U. Shipley, Stephen J. Freedland, Howard M. Sandler, Susan Halabi, Felix Y. Feng, James J. Dignam, Paul L. Nguyen, Matthew J. Schipper, Daniel E. Spratt
Randomized clinical trial of a family intervention for prostate cancer patients and their spouses
Laurel Northouse, Darlene Mood, Ann Schafenacker, James E. Montie, Howard M. Sandler, Jeffrey D. Forman, Maha Hussain, Kenneth J. Pienta, David C. Smith, Trace Kershaw
Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation Therapy
Shuang G. Zhao, S. Laura Chang, Nicholas Erho, Menggang Yu, Jonathan Lehrer, Mohammed Alshalalfa, Corey Speers, Matthew R. Cooperberg, Won Bae Kim, Charles J. Ryan, Robert B. Den, Stephen J. Freedland, Edwin M. Posadas, Howard M. Sandler, Eric A. Klein, Peter C. Black, Roland Seiler, Scott A. Tomlins, Arul M. Chinnaiyan, Robert B. Jenkins, Elai Davicioni, Ashley E. Ross, Edward M. Schaeffer, Paul L. Nguyen, Peter R. Carroll, R. Jeffrey Karnes, Daniel E. Spratt, Felix Y. Feng
Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials
Andre Esteva, Jean Feng, Douwe van der Wal, Shih-Cheng Huang, Jeffry Simko, Sandy DeVries, Emmalyn Chen, Edward M. Schaeffer, Todd M. Morgan, Yilun Sun, Amirata Ghorbani, Nikhil Naik, Dhruv Nathawani, Richard Socher, Jeff M. Michalski, Mack Roach, Thomas M. Pisansky, Jedidiah M. Monson, Farah Naz, James A. Wallace, Michelle Ferguson, Jean-Paul Bahary, James Zou, Matthew P. Lungren, Serena Yeung, Ashley E. Ross, Michael Jonathan Kucharczyk, Luís Souhami, Leslie Ballas, Christopher A. Peters, Sandy Liu, Alexander G. Balogh, Pamela Randolph-Jackson, David L. Schwartz, M.R. Girvigian, Naoyuki G. Saito, Adam Raben, Rachel Rabinovitch, Khalil Katato, Howard M. Sandler, Phuoc T. Tran, Daniel E. Spratt, Stephanie L. Pugh, Felix Y. Feng, Osama Mohamad